PD-L1 (encoded by CD274) is a transmembrane protein synthesized in the endoplasmic reticulum of tumor cells and its interaction with the programmed cell death protein 1 on T-cells restrains antitumor immunity by T-cell activation inhibition or apoptosis, thus leading to cancer’s immune evasion [15,17]. Here, PDCD1 is linked to neoplasm.